Jane Street Group, LLC Madrigal Pharmaceuticals, Inc. Put Options Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$212.22 - $292.96 $44.9 Million - $62 Million	211,500 New	211,500 $44.9 Million
Q1 2022 May 17, 2022	BUY	$55.89 - $101.89 $1.13 Million - $2.06 Million	20,200 Added 171.19%	32,000 $3.14 Million
Q4 2021 Feb 15, 2022	BUY	$72.34 - $95.09 $390,636 - $513,486	5,400 Added 84.38%	11,800 $1 Million
Q3 2021 Nov 16, 2021	SELL	$78.35 - $105.02 $94,020 - $126,024	-1,200 Reduced 15.79%	6,400 $511,000
Q2 2021 Aug 16, 2021	SELL	$97.2 - $137.59 $116,640 - $165,108	-1,200 Reduced 13.64%	7,600 $740,000
Q1 2021 May 18, 2021	SELL	$108.54 - $125.2 $1.88 Million - $2.17 Million	-17,300 Reduced 66.28%	8,800 $1.03 Million
Q3 2020 Nov 17, 2020	SELL	$99.78 - $124.21 $528,834 - $658,313	-5,300 Reduced 16.88%	26,100 $3.1 Million
Q2 2020 Aug 17, 2020	BUY	$60.13 - $125.71 $1.89 Million - $3.95 Million	31,400 New	31,400 $3.56 Million

297

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.28B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.